Ongoing Clinical Trials Ongoing Clinical Trials

Ongoing Clinical Trials

Home >> Clinical Trial Guidance >> Ongoing Clinical Trials

We inform you of the clinical trials that are being conducted by K-MASTER Precision Medicine Project Group.

* Protocol No. KM-11
* Research Title Combination chomotherapy of nanoxel and herzuma in patients with relapsed or metastatic salivary gland carcinoma : open label single arm multicenter phase II study
* Overall Research Director Ahn Myung Ju Affiliate Samsung Medical Center
Carcinoma Salivary gland cancer
Target Gene Her2 Clinical Trial Drug Nanoxel, Trastuzumab
Research period 2018.06.28 ~ 2021.12.31 Progress Status registering
Number of recipients 31 / 43 Registration rate 72.09%

Institutional research participation

No. Research manager Research institution

:: There is no registered research participant information. ::

prev list next

arrow Method of participation

If you want to participate in the clinical examination, please contact the email address below.

Email | CONTACT Secretariat 02.2286.1564 | Clinical Trial Coordinating Center 02.2286.1562